UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The P4-ATPase ATP9A is a novel determinant of exosome release

PloS one, 2019-04, Vol.14 (4), p.e0213069-e0213069

2019

Volltextzugriff (PDF)

Low efficacy of recombinant SV40 in Ugt1a1-/- mice with severe inherited hyperbilirubinemia

PloS one, 2021-01, Vol.16 (4), p.e0250605-e0250605

2021

Volltextzugriff (PDF)

What's next in gene therapy for Crigler-Najjar syndrome?

Expert opinion on biological therapy, 2023-02, Vol.23 (2), p.119-121

2023

Volltextzugriff (PDF)

Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects

International journal of molecular sciences, 2020-12, Vol.22 (1), p.273

2020

Volltextzugriff (PDF)

Therapeutic base editing in the adult liver

Nature reviews. Gastroenterology & hepatology, 2021-09, Vol.18 (9), p.597-598

2021

Volltextzugriff (PDF)

Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice

Journal of hepatology, 2019-07, Vol.71 (1), p.153-162

2019

Volltextzugriff (PDF)

Reduced spontaneous itch in mouse models of cholestasis

Scientific reports, 2021-03, Vol.11 (1), p.6127-6127, Article 6127

2021

Volltextzugriff (PDF)

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome

Human gene therapy, 2019-10, Vol.30 (10), p.1297-1305

2019

Volltextzugriff (PDF)

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome

Molecular therapy. Methods & clinical development, 2019-03, Vol.12, p.157-174

2019

Volltextzugriff (PDF)

A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report

BMC pediatrics, 2019-05, Vol.19 (1), p.173-173, Article 173

2019

Volltextzugriff (PDF)

Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients

Molecular therapy. Methods & clinical development, 2021-03, Vol.20, p.287-297

2021

Volltextzugriff (PDF)

Adeno-associated viral vector serotype 5 poorly transduces liver in rat models

PloS one, 2013-12, Vol.8 (12), p.e82597-e82597

2013

Volltextzugriff (PDF)

Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo

Scientific reports, 2017-05, Vol.7 (1), p.1646-9, Article 1646

2017

Volltextzugriff (PDF)

ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes

Hepatology (Baltimore, Md.), 2016-07, Vol.64 (1), p.161-174

2016

Volltextzugriff (PDF)

A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene

Molecular therapy. Methods & clinical development, 2020-09, Vol.18, p.250-258

2020

Volltextzugriff (PDF)

Disease burden and management of Crigler‐Najjar syndrome: Report of a world registry

Liver international, 2022-07, Vol.42 (7), p.1593-1604

2022

Volltextzugriff (PDF)

Gene Replacement Therapy for Genetic Hepatocellular Jaundice

Clinical reviews in allergy & immunology, 2015-06, Vol.48 (2-3), p.243-253

2015

Volltextzugriff (PDF)

An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective spf / ash Mouse Model of Ornithine Transcarbamylase Deficiency

International journal of molecular sciences, 2020-11, Vol.21 (22), p.8735

2020

Volltextzugriff (PDF)

The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function

Journal of Crohn's and colitis, 2024-08, Vol.18 (7), p.1134-1146

2024

Volltextzugriff (PDF)

A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome

Molecular therapy. Methods & clinical development, 2016-01, Vol.3 (C), p.16049-16049, Article 16049

2016

Volltextzugriff (PDF)

The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood

Gastroenterology (New York, N.Y. 1943), 2001-05, Vol.120 (6), p.1448-1458

2001

Volltextzugriff (PDF)

A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I

International journal of molecular sciences, 2020-03, Vol.21 (6), p.2136

2020

Volltextzugriff (PDF)

Enteroendocrine cells are a potential source of serum autotaxin in men

Biochimica et biophysica acta, 2016-04, Vol.1862 (4), p.696-704

2016

Volltextzugriff (PDF)

Long-Term Effects of Biliverdin Reductase a Deficiency in Ugt1 -/- Mice: Impact on Redox Status and Metabolism

Antioxidants, 2021-12, Vol.10 (12), p.2029

2021

Volltextzugriff (PDF)

The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's Syndrome

The New England journal of medicine, 1995-11, Vol.333 (18), p.1171-1175

1995

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(113)

Sprache

Englisch
(113)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The P4-ATPase ATP9A is a novel determinant of exosome release

Low efficacy of recombinant SV40 in Ugt1a1-/- mice with severe inherited hyperbilirubinemia

What's next in gene therapy for Crigler-Najjar syndrome?

Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects

Therapeutic base editing in the adult liver

Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice

Reduced spontaneous itch in mouse models of cholestasis

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome

A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report

Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients

Adeno-associated viral vector serotype 5 poorly transduces liver in rat models

Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo

ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes

A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene

Disease burden and management of Crigler‐Najjar syndrome: Report of a world registry

Gene Replacement Therapy for Genetic Hepatocellular Jaundice

An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective spf / ash Mouse Model of Ornithine Transcarbamylase Deficiency

The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function

A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome

The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood

A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I

Enteroendocrine cells are a potential source of serum autotaxin in men

Long-Term Effects of Biliverdin Reductase a Deficiency in Ugt1 -/- Mice: Impact on Redox Status and Metabolism

The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's Syndrome

Suchergebnisse filtern